{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:11:55Z","timestamp":1793045515316,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.cld.2022.01.001","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T07:27:05Z","timestamp":1648798025000},"page":"149-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Hyponatremia in Cirrhosis"],"prefix":"10.1016","volume":"26","author":[{"given":"Helbert","family":"Rondon-Berrios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos Q.","family":"Velez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cld.2022.01.001_bib1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.510280337","article-title":"Hyponatremia in cirrhosis: from pathogenesis to treatment","volume":"28","author":"Gines","year":"1998","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2022.01.001_bib2","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/hep.21412","article-title":"Hyponatremia in cirrhosis: results of a patient population survey","volume":"44","author":"Angeli","year":"2006","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2022.01.001_bib3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3904\/kjim.2009.24.2.106","article-title":"The association between the serum sodium level and the severity of complications in liver cirrhosis","volume":"24","author":"Kim","year":"2009","journal-title":"Korean J Intern Med"},{"issue":"4","key":"10.1016\/j.cld.2022.01.001_bib4","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1053\/j.gastro.2006.02.017","article-title":"Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation","volume":"130","author":"Londono","year":"2006","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2022.01.001_bib5","first-page":"401","article-title":"Hyponatremia in cirrhosis: risk factors and prognostic value","volume":"94","author":"Ennaifer","year":"2016","journal-title":"Tunis Med"},{"issue":"3","key":"10.1016\/j.cld.2022.01.001_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41581-019-0218-4","article-title":"Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis","volume":"16","author":"Velez","year":"2020","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.cld.2022.01.001_bib7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01095898","article-title":"Prognostic value of spontaneous hyponatremia in cirrhosis with ascites","volume":"21","author":"Arroyo","year":"1976","journal-title":"Am J Dig Dis"},{"issue":"10","key":"10.1016\/j.cld.2022.01.001_bib8","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.cld.2022.01.001_bib9","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/jlts.2002.35927","article-title":"The new liver allocation system: moving toward evidence-based transplantation policy","volume":"8","author":"Freeman","year":"2002","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.cld.2022.01.001_bib10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/lt.20329","article-title":"Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone","volume":"11","author":"Ruf","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2022.01.001_bib11","author":"UNfO"},{"issue":"6","key":"10.1016\/j.cld.2022.01.001_bib12","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/ajg.2009.293","article-title":"Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis","volume":"104","author":"Guevara","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2022.01.001_bib13","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.neuroscience.2010.03.042","article-title":"Brain volume regulation in response to changes in osmolality","volume":"168","author":"Verbalis","year":"2010","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.cld.2022.01.001_bib14","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0168-8278(01)00181-7","article-title":"The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation","volume":"35","author":"Cordoba","year":"2001","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2022.01.001_bib15","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/gut.2007.122176","article-title":"Pathogenetic mechanisms of hepatic encephalopathy","volume":"57","author":"Haussinger","year":"2008","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.cld.2022.01.001_bib16","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/0016-5085(94)90552-5","article-title":"Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy","volume":"107","author":"Haussinger","year":"1994","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2022.01.001_bib17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/hep.1840190113","article-title":"Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites","volume":"19","author":"Angeli","year":"1994","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2022.01.001_bib18","first-page":"229","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology","volume":"105","author":"Gines","year":"1993","journal-title":"Jul"},{"issue":"1","key":"10.1016\/j.cld.2022.01.001_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12325-012-0073-1","article-title":"Hyponatremia-associated healthcare burden among US patients hospitalized for cirrhosis","volume":"30","author":"Deitelzweig","year":"2013","journal-title":"Adv Ther"},{"issue":"6","key":"10.1016\/j.cld.2022.01.001_bib20","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jhep.2012.07.020","article-title":"Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema","volume":"57","author":"Sola","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2022.01.001_bib21","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/lt.21154","article-title":"The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study","volume":"13","author":"Dawwas","year":"2007","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1016\/j.cld.2022.01.001_bib22","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/lt.25327","article-title":"Hyponatremia in cirrhosis: Implications for liver transplantation","volume":"24","author":"Leise","year":"2018","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2022.01.001_bib23","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/lt.23860","article-title":"Effect of the pretransplant serum sodium concentration on outcomes following liver transplantation","volume":"20","author":"Leise","year":"2014","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.cld.2022.01.001_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-2007-1007196","article-title":"Pathogenesis of ascites in cirrhosis","volume":"17","author":"Gines","year":"1997","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2022.01.001_bib25","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s12072-012-9397-9","article-title":"Nitric oxide and prostaglandin as mediators in the pathogenesis of hyperkinetic circulatory state in a model of endotoxemia-induced portal hypertension","volume":"7","author":"Rizvi","year":"2013","journal-title":"Hepatol Int"},{"issue":"5","key":"10.1016\/j.cld.2022.01.001_bib26","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"issue":"7 Suppl 1","key":"10.1016\/j.cld.2022.01.001_bib27","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.amjmed.2006.05.007","article-title":"Water and sodium retention in edematous disorders: role of vasopressin and aldosterone","volume":"119","author":"Schrier","year":"2006","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.cld.2022.01.001_bib28","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI103655","article-title":"Total exchangeable sodium, total exchangeable potassium, and total body water in edematous patients with cirrhosis of the liver and congestive heart failure","volume":"37","author":"Birkenfeld","year":"1958","journal-title":"J\u00a0Clin Invest"},{"issue":"9","key":"10.1016\/j.cld.2022.01.001_bib29","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1172\/JCI103712","article-title":"Interrelations between serum sodium concentration, serum osmolarity and total exchangeable sodium, total exchangeable potassium and total body water","volume":"37","author":"Edelman","year":"1958","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.cld.2022.01.001_bib30","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1053\/j.ajkd.2009.12.024","article-title":"A\u00a0patient with severe hyponatremia and hypokalemia: osmotic demyelination following potassium repletion","volume":"55","author":"Berl","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.cld.2022.01.001_bib31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1751-7176.2008.08063.x","article-title":"Well tolerated spironolactone-related hyponatremia","volume":"10","author":"Handler","year":"2008","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"issue":"11","key":"10.1016\/j.cld.2022.01.001_bib32","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.dld.2018.05.011","article-title":"Relative adrenal insufficiency in cirrhotic patients with ascites (hepatoadrenal syndrome)","volume":"50","author":"Singh","year":"2018","journal-title":"Dig Liver Dis"},{"issue":"6","key":"10.1016\/j.cld.2022.01.001_bib33","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/01.CCM.0000164541.12106.57","article-title":"Hepatic Cortisol R, Adrenal Pathophysiology Study G. The hepatoadrenal syndrome: a common yet unrecognized clinical condition","volume":"33","author":"Marik","year":"2005","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.cld.2022.01.001_bib34","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/jgh3.12254","article-title":"A\u00a0retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension","volume":"4","author":"Han","year":"2020","journal-title":"JGH Open"},{"issue":"5","key":"10.1016\/j.cld.2022.01.001_bib35","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/14740338.2020.1734558","article-title":"Development of hyponatremia after terlipressin in cirrhotic patients with acute gastrointestinal bleeding: a retrospective multicenter observational study","volume":"19","author":"Xu","year":"2020","journal-title":"Expert Opin Drug Saf"},{"issue":"9","key":"10.1016\/j.cld.2022.01.001_bib36","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome","volume":"384","author":"Wong","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.cld.2022.01.001_bib37","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.ajem.2017.10.065","article-title":"Beer potomania: Atypical cause of severe hyponatremia in older alcoholics","volume":"36","author":"Ouellette","year":"2018","journal-title":"Am J Emerg Med"},{"issue":"2","key":"10.1016\/j.cld.2022.01.001_bib38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/jcp.42.2.167","article-title":"Pseudohyponatraemia, hypercholesterolaemia, and primary biliary cirrhosis","volume":"42","author":"Hickman","year":"1989","journal-title":"J\u00a0Clin Pathol"},{"issue":"4","key":"10.1016\/j.cld.2022.01.001_bib39","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.kint.2020.05.015","article-title":"Hyponatremia in the cancer patient","volume":"98","author":"Workeneh","year":"2020","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.cld.2022.01.001_bib40","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1681\/ASN.2006111302","article-title":"Decreased effective blood volume in edematous disorders: what does this mean?","volume":"18","author":"Schrier","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.cld.2022.01.001_bib41","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/hep.22418","article-title":"Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management","volume":"48","author":"Gines","year":"2008","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2022.01.001_bib42","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0002-9343(87)90649-8","article-title":"Clinical assessment of extracellular fluid volume in hyponatremia","volume":"83","author":"Chung","year":"1987","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.cld.2022.01.001_bib43","first-page":"13","article-title":"Point-of-care ultrasound to evaluate volume status in severe hyponatremia","author":"Evins","year":"2020","journal-title":"BMJ Case Rep"},{"issue":"3","key":"10.1016\/j.cld.2022.01.001_bib44","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000501299","article-title":"Point-of-Care Echocardiography Unveils misclassification of acute kidney injury as hepatorenal syndrome","volume":"50","author":"Velez","year":"2019","journal-title":"Am J Nephrol"},{"issue":"Suppl 2","key":"10.1016\/j.cld.2022.01.001_bib45","first-page":"i1","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemia","volume":"29","author":"Spasovski","year":"2014","journal-title":"Nephrol Dial Transpl Apr"},{"issue":"10 Suppl 1","key":"10.1016\/j.cld.2022.01.001_bib46","first-page":"S1","article-title":"Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations","volume":"126","author":"Verbalis","year":"2013","journal-title":"Am J Med Oct"},{"issue":"9","key":"10.1016\/j.cld.2022.01.001_bib47","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.34067\/KID.0004402021","article-title":"Osmotic demyelination syndrome following correction of hyponatremia by \u226410 mEq\/L per day","volume":"2","author":"Tandukar","year":"2021","journal-title":"Kidney360"},{"issue":"1","key":"10.1016\/j.cld.2022.01.001_bib48","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamainternmed.2020.5519","article-title":"Risk of overcorrection in rapid Intermittent bolus vs slow continuous infusion therapies of hypertonic saline for patients with symptomatic hyponatremia: the SALSA randomized clinical trial","volume":"181","author":"Baek","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.cld.2022.01.001_bib49","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1053\/gast.2003.50143","article-title":"Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial","volume":"124","author":"Gerbes","year":"2003","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2022.01.001_bib50","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.22293","article-title":"Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial","volume":"48","author":"Gines","year":"2008","journal-title":"Hepatol"},{"key":"10.1016\/j.cld.2022.01.001_bib51","doi-asserted-by":"crossref","first-page":"1579508","DOI":"10.1155\/2018\/1579508","article-title":"Management Strategies and outcomes for hyponatremia in cirrhosis in the hyponatremia registry","volume":"2018","author":"Sigal","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2022.01.001_bib52","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM196502252720802","article-title":"Renal effects of acute expansion of plasma volume in cirrhosis","volume":"272","author":"Vlahcevic","year":"1965","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cld.2022.01.001_bib53","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/gut.31.2.204","article-title":"Intravenous albumin infusion is an effective therapy for hyponatraemia in cirrhotic patients with ascites","volume":"31","author":"McCormick","year":"1990","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.cld.2022.01.001_bib54","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/s41395-018-0119-3","article-title":"The impact of albumin Use on resolution of hyponatremia in hospitalized patients with cirrhosis","volume":"113","author":"Bajaj","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"10138","key":"10.1016\/j.cld.2022.01.001_bib55","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cld.2022.01.001_bib56","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0002-9343(80)90506-9","article-title":"Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by urea","volume":"69","author":"Decaux","year":"1980","journal-title":"Am J Med"},{"issue":"6484","key":"10.1016\/j.cld.2022.01.001_bib57","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1136\/bmj.290.6484.1782","article-title":"Use of urea for treatment of water retention in hyponatraemic cirrhosis with ascites resistant to diuretics","volume":"290","author":"Decaux","year":"1985","journal-title":"Br Med J (Clin Res Ed"},{"issue":"4","key":"10.1016\/j.cld.2022.01.001_bib58","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000184016","article-title":"Treatment of hyponatremic cirrhosis with ascites resistant to diuretics by urea","volume":"44","author":"Decaux","year":"1986","journal-title":"Nephron"},{"issue":"1\u20132","key":"10.1016\/j.cld.2022.01.001_bib59","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000503773","article-title":"Urea for chronic hyponatremia","volume":"49","author":"Rondon-Berrios","year":"2020","journal-title":"Blood Purif"},{"issue":"23","key":"10.1016\/j.cld.2022.01.001_bib60","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMra1403672","article-title":"Vasopressin antagonists","volume":"372","author":"Berl","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.cld.2022.01.001_bib61","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.amjmed.2016.09.011","article-title":"Limited efficacy of tolvaptan in patients with cirrhosis and severe hyponatremia: real-life experience","volume":"130","author":"Pose","year":"2017","journal-title":"Am J Med"},{"issue":"20","key":"10.1016\/j.cld.2022.01.001_bib62","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.cld.2022.01.001_bib63","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2011.08.020","article-title":"Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis","volume":"56","author":"Cardenas","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2022.01.001_bib64","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1681\/ASN.2009080857","article-title":"Oral tolvaptan is safe and effective in chronic hyponatremia","volume":"21","author":"Berl","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.cld.2022.01.001_bib65","doi-asserted-by":"crossref","first-page":"977 e1","DOI":"10.1016\/j.amjmed.2011.04.028","article-title":"Short-term efficacy and safety of vasopressin receptor antagonists for treatment of hyponatremia","volume":"124","author":"Jaber","year":"2011","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.cld.2022.01.001_bib66","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1053\/j.ajkd.2010.01.013","article-title":"Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis","volume":"56","author":"Rozen-Zvi","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.cld.2022.01.001_bib67","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.beem.2016.02.004","article-title":"Vasopressin receptor antagonists: Characteristics and clinical role","volume":"30","author":"Rondon-Berrios","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.cld.2022.01.001_bib68","first-page":"315","article-title":"Conivaptan: a step forward in the treatment of hyponatremia?","volume":"4","author":"Hline","year":"2008","journal-title":"Ther Clin Risk Manag"},{"issue":"25","key":"10.1016\/j.cld.2022.01.001_bib69","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2022.01.001_bib70","author":"US Food and Drug Administration"},{"issue":"10","key":"10.1016\/j.cld.2022.01.001_bib71","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1111\/ajt.14317","article-title":"Prevention of the osmotic demyelination syndrome after liver transplantation: a multidisciplinary Perspective","volume":"17","author":"Crismale","year":"2017","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.cld.2022.01.001_bib72","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/0886022X.2014.975102","article-title":"Serum sodium shift in hyponatremic patients undergoing liver transplantation: a retrospective cohort study","volume":"37","author":"Romanovsky","year":"2015","journal-title":"Ren Fail"},{"issue":"5","key":"10.1016\/j.cld.2022.01.001_bib73","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/hep.22846","article-title":"Impact of pretransplant hyponatremia on outcome following liver transplantation","volume":"49","author":"Yun","year":"2009","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2022.01.001_bib74","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/TP.0000000000000496","article-title":"Risk factors for central pontine and extrapontine myelinolysis after liver transplantation: a single-center study","volume":"99","author":"Crivellin","year":"2015","journal-title":"Transplant"},{"issue":"12","key":"10.1016\/j.cld.2022.01.001_bib75","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/ene.12571","article-title":"Central pontine and extrapontine myelinolysis: a systematic review","volume":"21","author":"Singh","year":"2014","journal-title":"Eur J Neurol"},{"issue":"6","key":"10.1016\/j.cld.2022.01.001_bib76","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000242426","article-title":"Risk factors for central pontine and extrapontine myelinolysis following orthotopic liver transplantation","volume":"62","author":"Lee","year":"2009","journal-title":"Eur Neurol"},{"issue":"2","key":"10.1016\/j.cld.2022.01.001_bib77","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12028-013-9928-9","article-title":"Identifying risk factors for central pontine and extrapontine myelinolysis after liver transplantation: a case-control study","volume":"20","author":"Morard","year":"2014","journal-title":"Neurocrit Care"},{"issue":"2","key":"10.1016\/j.cld.2022.01.001_bib78","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.sult.2013.09.009","article-title":"Osmotic demyelination syndrome: central pontine myelinolysis and extrapontine myelinolysis","volume":"35","author":"Alleman","year":"2014","journal-title":"Semin Ultrasound CT MR"},{"issue":"6","key":"10.1016\/j.cld.2022.01.001_bib79","first-page":"689","article-title":"Short-term, low-dose Use of tolvaptan as a Bridge therapy to expedite liver transplant for severe hyponatremic, cirrhotic patients with high model for end-stage liver disease scores","volume":"15","author":"Lenci","year":"2017","journal-title":"Exp Clin Transpl"},{"issue":"2","key":"10.1016\/j.cld.2022.01.001_bib80","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/lt.24982","article-title":"Novel intraoperative management in the model for end-stage liver disease-sodium era: continuous venovenous hemofiltration for severe hyponatremia in liver transplantation","volume":"24","author":"Nagai","year":"2018","journal-title":"Liver Transpl"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:58:54Z","timestamp":1761069534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326122000010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1089326122000010"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2022.01.001","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyponatremia in Cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2022.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}